UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
progression-free survival (3528) 3528
science & technology (3330) 3330
life sciences & biomedicine (3287) 3287
humans (3106) 3106
female (2465) 2465
middle aged (2188) 2188
male (2129) 2129
oncology (2126) 2126
aged (2001) 2001
adult (1501) 1501
retrospective studies (988) 988
prognosis (960) 960
overall survival (918) 918
aged, 80 and over (916) 916
treatment outcome (852) 852
cancer (813) 813
chemotherapy (795) 795
disease-free survival (764) 764
patients (671) 671
antineoplastic combined chemotherapy protocols - therapeutic use (628) 628
survival (626) 626
metastasis (622) 622
care and treatment (581) 581
time factors (554) 554
analysis (548) 548
kaplan-meier estimate (546) 546
surgery (483) 483
disease progression (470) 470
risk factors (461) 461
young adult (448) 448
neoplasm staging (438) 438
tumors (437) 437
medical prognosis (405) 405
survival rate (393) 393
research (387) 387
survival analysis (378) 378
clinical trials (367) 367
development and progression (367) 367
antineoplastic agents - therapeutic use (360) 360
medicine & public health (353) 353
follow-up studies (349) 349
cancer therapies (317) 317
progression free survival (317) 317
adolescent (315) 315
patient outcomes (313) 313
metastases (294) 294
proportional hazards models (290) 290
hematology (289) 289
abridged index medicus (276) 276
medical research (260) 260
antineoplastic combined chemotherapy protocols - adverse effects (259) 259
prospective studies (253) 253
drug therapy (247) 247
mutation (241) 241
breast cancer (237) 237
neurosciences & neurology (233) 233
lung neoplasms - drug therapy (229) 229
lung cancer (224) 224
original (223) 223
neoplasm metastasis (222) 222
clinical neurology (220) 220
multivariate analysis (212) 212
progression‐free survival (210) 210
randomized controlled trials as topic (210) 210
cardiovascular system & cardiology (204) 204
health aspects (203) 203
neoplasms. tumors. oncology. including cancer and carcinogens (203) 203
toxicity (201) 201
ovarian cancer (200) 200
medicine, experimental (198) 198
studies (196) 196
pharmacology & pharmacy (194) 194
carcinoma, non-small-cell lung - drug therapy (192) 192
general & internal medicine (190) 190
lung neoplasms - pathology (189) 189
antineoplastic combined chemotherapy protocols - administration & dosage (186) 186
medicine, general & internal (184) 184
radiation therapy (180) 180
radiotherapy (180) 180
risk assessment (180) 180
colorectal cancer (177) 177
biomarkers (176) 176
original article (175) 175
usage (175) 175
research article (171) 171
lung neoplasms - mortality (166) 166
radiology, nuclear medicine & medical imaging (166) 166
child (165) 165
quality of life (161) 161
immunotherapy (159) 159
recurrence (156) 156
antineoplastic agents - adverse effects (154) 154
carcinoma, non-small-cell lung - pathology (152) 152
predictive value of tests (151) 151
urology & nephrology (147) 147
antineoplastic agents - administration & dosage (144) 144
genetic aspects (144) 144
hematology, oncology and palliative medicine (144) 144
medicine, research & experimental (141) 141
research & experimental medicine (141) 141
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4040) 4040
Chinese (46) 46
Korean (23) 23
Russian (18) 18
German (17) 17
Spanish (12) 12
French (11) 11
Japanese (7) 7
Czech (5) 5
Hungarian (5) 5
Portuguese (5) 5
Polish (4) 4
Turkish (4) 4
Arabic (1) 1
Dutch (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 01/2019, Volume 14, Issue 1, pp. 124 - 129
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2018, Volume 36, Issue 4, pp. 383 - 390
Journal Article
Haematologica (Roma), ISSN 1592-8721, 10/2007, Volume 92, Issue 10, pp. 1399 - 1406
...). While in general these data support the association between maximal tumor response and overall survival or progression-free survival after HDT/SCT, some trials have failed to find such correlation... 
Long-term survival | High-dose therapy | Progression-free survival | Multiple myeloma | Dose-Response Relationship, Drug | Multiple Myeloma - drug therapy | Multiple Myeloma - pathology | Time Factors | Humans | Survival Rate | Treatment Outcome | Disease Progression | Life Sciences & Biomedicine | Hematology | Science & Technology | Index Medicus
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2018, Volume 19, Issue 10, pp. 1315 - 1327
Journal Article
Journal Article